NEW YORK, Nov. 10, 2016 /PRNewswire/ -- Respiratory Care Diagnostic devices are the devices which are used for the diagnosis of respiratory diseases such as Pneumonia, Asthma, Bronchitis, Sleep Apnea, cystic and pulmonary fibrosis, Tuberculosis, COPD (Chronic Obstructive Pulmonary Disease) etc. The Respiratory Care Device global market is segmented based on the products, applications, end-users and geography. Products are divided into Therapeutic device, Monitoring Device, Diagnostic Device and Consumables. Therapeutic devices include humidifiers, nebulizers, oxygen concentrators, Positive airway pressure (PAP) device, resuscitators, ventilators, inhalers and others. Humidifiers are further segmented into passive and active humidifiers. Nebulizers are segmented into jet nebulizers, ultrasonic nebulizers, mesh nebulizers and smart nebulizers.
Oxygen concentrators are divided into stationary oxygen concentrators and portable oxygen concentrators. Positive airway pressure devices are further segmented such as continuous positive airway pressure (CPAP) devices, Automatic PAP (APAP) devices, Bi-level PAP devices (BPAP) devices. Resuscitators are classified as manual and gas powered resuscitators. Ventilators are further segmented into non invasive and invasive ventilators. Inhalers are segmented such as dry powdered inhaler and metered dose inhaler. Monitoring device market is segmented into Pulse Oximeters, Capnographs and Gas Analyzers. Pulse Oximeters are further classified into Finger Pulse Oximeters, Handheld Pulse Oximeters, Wrist Pulse Oximeters, and Tabletop Pulse Oximeters. Diagnostic segments are divided into Spirometers, Peak Flow Meters, Polysomnographs device (PSG), where in Spirometers are further classified into Volumetric Spirometers and Flow Measuring Spirometers. PSG devices are classified into Clinical Polysomnographs devices and Ambulatory Polysomnographs devices. Consumables are divided into masks, tracheostomy tubes, nasal cannulas and others. Masks are segmented into Nasal masks, Full face masks, Nasal pillow masks, and Oral masks and others which include Non rebreather masks and Pocket masks.
By application, the Respiratory Care Device markets are divided into Acute Respiratory distress syndrome, asthma, Chronic Obstructive pulmonary diseases, Pulmonary fibrosis, Cystic fibrosis, Pneumonia, Respiratory failure, Restrictive lung diseases, Sleep Apnea and Tuberculosis, Lung Cancer and Others. Chronic Obstructive pulmonary diseases are further divided into chronic bronchitis and emphysema. Based on the end- users they are segmented into hospitals and home healthcare.
Among the Respiratory Care Devices products, therapeutic devices market dominated the products market by occupying a largest share as well as fastest growing segment from 2015 to 2022. In applications, the asthma is the largest market share and COPD is the fastest growing segment from 2015 to 2022. By end- users, hospitals is the largest segment with a share of 52.4% and, home care is the fastest segment with a CAGR from 2015 to 2022.Geographical wise, North America is the largest market, with a share of 45.2% followed by Europe and Asia. The APAC region is the fastest growing region from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the Respiratory Care Device market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The Respiratory Care Device market is expected to grow steadily at a high single digit CAGR from 2015 to 2022. The factors driving the growth of this market are increasing incidences of respiratory diseases such as Respiratory failure, COPD, asthma, sleep apnea, cystic fibrosis, Pneumonia, Tuberculosis etc. Urbanization and increasing pollution is one of the factor driving the respiratory care device market, new technology products boosting respiratory care device products market growth, increase in aging population, Increasing prevalence of tobacco usage, Increasing preterm birth incidence, rising use of non invasive ventilators and government initiatives and wide range of available products likely to propel the respiratory care device market. In addition to this, Growing Demand for Home Care Therapeutic Devices, Huge Pool of Undiagnosed Sleep Apnea Patients, Increasing COPD, leading to increasing the requirement of ventilators, healthy growth in the innovative products and acquisitions to open an array of opportunities for the market to flourish are some of the opportunities that are propelling the growth of the market. However, Lack of awareness of the disease, Large Under diagnosed and Undertreated Population, Harmful Effects of Certain Devices on Neonates and reluctance in adoption of new technologies are hampering the growth of the market. The threats for the respiratory care device market include Availability of low cost products from local manufacturers, stringent regulations for approval and mandatory licensing for Practitioners and Reimbursement issues.